Theravance Biopharma TBPH
TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Divestments (2020)

Updated

Theravance Biopharma's Divestments came in at $2.71 million for FY2022.

Analysis

Theravance Biopharma (TBPH) Divestments (2020) Analysis & Trends

  • Divestments carries a four-year compound annual growth rate of -39.3% (FY2018 to FY2022).
  • The FY2022 figure represents the highest annual Divestments since FY2019.
  • Per Business Quant, earlier years put Divestments at $5 million in FY2019 (-75.0%) and $20 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 62.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Theravance Biopharma 883.70 Mn -543.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 14.93 Mn
API Access

Theravance Biopharma Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=TBPH&period=max&api_key=YOUR_API_KEY